Cystic fibrosis: a treatment could nest in the starfish

The oceans are full of molecules capable of treating many diseases. One of them, roscovitine, could be effective against cystic fibrosis, a rare genetic disease that affects nearly 6,500 French. It is currently being evaluated. Continue reading Cystic fibrosis: a treatment could nest in the starfish

Potential Treatment for Cystic Fibrosis

Catabasis Pharmaceuticals to Present CAT-5571, a Novel Activator of Autophagy, as a Potential Treatment for Cystic Fibrosis at the 30th Annual North American Cystic Fibrosis Conference

http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=187116#.WA6VFKOZO8U

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that CAT-5571, a novel activator Continue reading Potential Treatment for Cystic Fibrosis

Viruses turbo-charge bacterial evolution in cystic fibrosis infections

http://www.medicalnewstoday.com/releases/311450.php

Scientists in the UK have found new evidence that tiny viruses called bacteriophages turbo-charge the evolution of bacteria that cause lung infections in Cystic Fibrosis patients. Continue reading Viruses turbo-charge bacterial evolution in cystic fibrosis infections

Polyphor AG: Polyphor successfully completes clinical Phase I study with POL6014 targeting life threatening lung diseases including cystic fibrosis

Polyphor successfully completes clinical Phase I study with POL6014 targeting life threatening lung diseases including cystic fibrosis

Allschwil, Switzerland, June 06, 2016. Polyphor Ltd today announced the successful completion of its clinical Phase I study with inhaled POL6014 in healthy volunteers. The macrocycle drug candidate POL6014 is a highly selective, Continue reading Polyphor AG: Polyphor successfully completes clinical Phase I study with POL6014 targeting life threatening lung diseases including cystic fibrosis

Antibiotic Against Superbug Biofilms, RSV

A potential drug therapy developed at the University of Pittsburgh Center for Vaccine Research (CVR) has proven effective against tough bacterial biofilms and a deadly respiratory virus simultaneously. The drug outperforms Continue reading Antibiotic Against Superbug Biofilms, RSV

Raptor Pharmaceutical Launches QUINSAIR™ in Europe

http://www.nasdaq.com/press-release/raptor-pharmaceutical-launches-quinsair-in-europe-20160411-00214

First-in-Class Inhaled Fluoroquinolone Therapy for Cystic Fibrosis Patients
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its first commercial sale of QUINSAIR™ (levofloxacin inhalation solution) in Continue reading Raptor Pharmaceutical Launches QUINSAIR™ in Europe

AmpliPhi Biosciences Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

http://www.businesswire.com/news/home/20160412006706/en/AmpliPhi-Biosciences-Presents-Data-Showing-Bacteriophage-Product

AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Continue reading AmpliPhi Biosciences Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

Raptor Announces Qualified Infectious Disease Product (QIDP) Designation for MP-376, Inhaled Levofloxacin

http://finance.yahoo.com/news/raptor-announces-qualified-infectious-disease-113000057.html

Raptor Pharmaceutical Corp. (RPTP) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation to MP-376, the Continue reading Raptor Announces Qualified Infectious Disease Product (QIDP) Designation for MP-376, Inhaled Levofloxacin

Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Montreal-based Laurent Pharmaceuticals recently announced the closing of a financing round, led by new investor Cystic Fibrosis Canada. The round included existing investors such as Aligo Innovation LP and Anges Quebec, and was promoted to allow the company to start preparing its upcoming Continue reading Laurent Pharma to Prepare Phase 2 Trial for Cystic Fibrosis on Heels of New Financing Round

Evolving insights into cystic fibrosis lung infections

http://medicalxpress.com/news/2016-03-evolving-insights-cystic-fibrosis-lung.html

Recent research progress into how bacteria adapt and evolve during chronic lung infections in cystic fibrosis patients could lead to better treatment strategies being developed, according to a new review by the University of Continue reading Evolving insights into cystic fibrosis lung infections